![]() |
Volumn 11, Issue 18, 2012, Pages 3343-3344
|
A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD27 ANTIBODY;
CD40 ANTIGEN;
CYTOKINE RECEPTOR AGONIST;
FAS ASSOCIATED DEATH DOMAIN PROTEIN;
FC RECEPTOR IIB;
HLA DR5 ANTIGEN;
IMMUNOGLOBULIN G2A;
IMMUNOGLOBULIN G2B;
TUMOR NECROSIS FACTOR RECEPTOR;
TUMOR NECROSIS FACTOR RECEPTOR ANTIBODY;
UNCLASSIFIED DRUG;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ANTIBODY SPECIFICITY;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CELL ACTIVATION;
DRUG RECEPTOR BINDING;
EDITORIAL;
HUMAN;
IMMUNE RESPONSE;
LARGE CELL LYMPHOMA;
LIVER TOXICITY;
NONHUMAN;
PROTEIN EXPRESSION;
SIGNAL TRANSDUCTION;
|
EID: 84866767643
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.21842 Document Type: Editorial |
Times cited : (30)
|
References (10)
|